0->"

Analyze Clinical Trial Reports (CTRs) and domain expert statements to ascertain semantic entailment or support. Focus on four CTR sections: (1) ELIGIBILITY CRITERIA, specifying conditions for patient inclusion, (2) INTERVENTION, detailing treatment specifics such as type, dosage, frequency, and duration, (3) RESULTS, summarizing participant count, outcome measures, units, and conclusions, and (4) ADVERSE EVENTS, documenting observed patient signs and symptoms. Cross-examine these sections with expert statements, ensuring claims are consistent with, supported by, and non-contradictory to the CTRs' content.
----------
1->

Perform an exhaustive analysis of Clinical Trial Reports (CTRs), meticulously dissecting the following pivotal components:

1. ELIGIBILITY CRITERIA: Critically evaluate the patient selection inclusion conditions.

2. INTERVENTION: Examine in detail the treatment specifics, including type, dosage, administration frequency, and trial duration.

3. RESULTS: Provide a comprehensive summary of participant counts, outcome measures, units of measurement, and conclusions.

4. ADVERSE EVENTS: Thoroughly document any observed patient signs and symptoms.

Cross-reference these components with expert domain statements to affirm semantic entailment or corroboration, ensuring that claims are consistent with, corroborated by, and non-contradictory to the content of the CTRs.
----------
2->

Conduct an in-depth analysis of Clinical Trial Reports (CTRs), focusing on eligibility criteria for participant selection, treatment specifics including type, dosage, frequency, and duration, results summarizing participant count, outcome measures, units, and conclusions, as well as adverse events documenting patient signs and symptoms. Cross-reference these details with domain expert statements to verify semantic consistency, support, and non-contradiction between the CTRs and expert insights.
----------
3->

Perform an in-depth analysis of Clinical Trial Reports (CTRs), concentrating on four pivotal elements: 

1. ELIGIBILITY CRITERIA: Evaluate the inclusion conditions for patient selection.

2. INTERVENTION: Examine the treatment specifics, including type, dosage, administration frequency, trial duration.

3. RESULTS: Summarize participant counts, outcome measures, units of measurement, and conclusions.

4. ADVERSE EVENTS: Document any observed patient signs and symptoms.

Cross-reference these elements with expert statements to confirm semantic entailment or support, ensuring claims are consistent with, corroborated by, and non-contradictory to the CTRs' content.
----------
4->

Examine Clinical Trial Reports (CTRs) and statements from domain experts to determine if there is semantic support or entailment. Specifically, scrutinize the following CTR sections: (1) ELIGIBILITY CRITERIA, which outlines the inclusion conditions for patients, (2) INTERVENTION, detailing the treatment type, dosage, administration frequency, and treatment duration, (3) RESULTS, which includes the number of participants, outcome measures, units of measurement, and conclusions, and (4) ADVERSE EVENTS, which records any observed patient signs and symptoms. Validate these sections against expert statements to confirm that claims align with, are substantiated by, and do not contradict the content of the CTRs.
----------
